av/inflarx--big.svg

DE:INFLARX

InflaRx

  • Stock

Last Close

1.57

05/11 21:00

Market Cap

95.39M

Beta: -

Volume Today

63.83K

Avg: -

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-...Show More

competitor of